arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Scotts Miracle-Gro Company (The)

SMG Industrials Agricultural Chemicals
$59.15
▲ +5.9% Today
as of Oct 22, 16:52 ET
Last 30 days +5.80% Sep 14 → Oct 22
$47.58 $50.69 $53.80 $56.90 $60.01 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$55.55
High
$59.25
Low
$55.52
Volume
$1M
Avg Vol
$931,986
Mkt Cap
$2.9B
P/E (TTM)
14.44
Beta
—
52w High
$75.34
52w Low
$47.90
Div Yield
—
Shares Out
$58M

Recent Press Releases & News last 60 days · 14 items

Oct 23 · 04:28 Simply Wall St.
Scotts Miracle Gro (SMG) Stock Still Looks Undervalued After A 51% Five Year Slump
Oct 15 · 17:15 MT Newswires
Scotts Miracle-Gro's Recent Share Pullback Creates 'Attractive' Risk/Reward Setup, UBS Says
Oct 15 · 14:34 MT Newswires
UBS Upgrades Scotts Miracle-Gro to Buy From Neutral, Adjusts Price Target to $70 From $78
▸ Show all 14 press releases & news Free account →

SMG earnings at a glance

Scotts Miracle-Gro Company (The) (SMG) is scheduled to report earnings on Wednesday, November 4, 2026 before the market opens — in 12 days. Analysts expect earnings per share of -$2.22, compared with -$1.96 in the same quarter last year (-13%). The options market is pricing a move of about ±4.4% after the report, a range of roughly $56.54 to $61.76 from today's $59.15. Over its last 6 reports the stock rose the next day 1 time and fell 5, moving ±4.4% on average; after the most recent report on Jul 29, 2026 it moved -3.8%. That means options currently expect about the same movement than SMG has typically delivered. SMG beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 37%. The share price of $59.15 sits in the middle of its 52-week range.

More Industrials stocks · All stocks · Earnings calendar

Overview

52-week range
$48
$75
41% of range
Avg surprise (last 6)
+11.0%
Avg reaction (last 6)
-3.4%
17% positive
Latest IV / EM
37%
EM ±4.4% · $50 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.16$-0.49$1.19$2.86$4.53 Actual $0.77Actual $-1.42Actual $2.74Actual $2.28Actual $-1.21Actual $3.98Est $3.95Actual $2.59Est $2.19Actual $-1.96Est $-1.88Actual $-2.16Actual $-0.77Est $-1.04Actual $4.53Est $3.97Actual $2.82Est $2.53 JulDecMarJunDecMar/2025Jun/2025Sep/2025Dec8K8KJun/2026
Revenue vs Net Income Revenue Net income
$-125M$289M$704M$1.1B$1.5B Dec 24Mar 25Jun 25Dec 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 29, 2026Jun/2026 $2.82 $2.53 +11.5% -2.3% -3.8% earnings
Wed Apr 29, 20268K 2026-04-29 $4.53 $3.97 +14.1% — -4.5% earnings
Wed Jan 28, 20268K 2026-01-28 $-0.77 $-1.04 +26.0% — -0.7% earnings
Sat Dec 27, 2025Dec 2025 $-2.16 — — — — financials
Wed Nov 5, 2025Sep/2025 $-1.96 $-1.88 -4.3% — +2.9% earnings
Wed Jul 30, 2025Jun/2025 $2.59 $2.19 +18.3% — -8.5% earnings
Wed Apr 30, 2025Mar/2025 $3.98 $3.95 +0.8% — -5.9% earnings
Sat Dec 28, 2024Dec 2024 $-1.21 — — — — financials
Sat Jun 29, 2024Jun 2024 $2.28 — — — — financials
Sat Mar 30, 2024Mar 2024 $2.74 — — — — financials
Sat Dec 30, 2023Dec 2023 $-1.42 — — — — financials
Sat Jul 1, 2023Jul 2023 $0.77 — — — — financials
Sat Apr 1, 2023Apr 2023 $1.94 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026BMO -$2.22-$1.96 -13.3%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.17B$1.46B$354M—$1.16B$1.39B$367M—
Cost of revenue$805M$849M$264M—$785M$842M$277M—
Gross profit$366M$610M$89M—$373M$542M$88M—
Operating income$170M$402M$-22M—$222M$350M$-46M—
Net income$112M$239M$-125M—$149M$218M$-70M—
EPS (diluted)$1.90$4.04$-2.16—$2.54$3.72$-1.21—

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$28M$6M$8M$33M$40M$9M$6M$72M
Inventory$481M$696M$847M$543M$485M$710M$845M$588M
Total current assets$1.35B$1.62B$1.26B$940M$1.28B$1.73B$1.29B$980M
Total assets$3.17B$3.41B$3.03B$2.74B$3.09B$3.54B$3.17B$2.87B
Long-term debt$1.84B$2.07B$2.25B$2.05B$2.14B$2.49B$2.64B$2.17B
Total liabilities$3.38B$3.70B$3.53B$3.10B$3.26B$3.83B$3.65B$3.26B
Total equity$-209M$-286M$-501M$-358M$-171M$-290M$-480M$-391M

Implied volatility — last 90 days

35%58%81%105%128% Jun 07 — IV 55% · EM ±7.6%Jun 08 — IV 51% · EM ±6.8%Jun 09 — IV 53% · EM ±6.6%Jun 10 — IV 53% · EM ±6.3%Jun 11 — IV 59% · EM ±6.5%Jun 12 — IV 54% · EM ±5.5%Jun 15 — IV 64% · EM ±4.6%Jun 16 — IV 42% · EM ±2.5%Jun 17 — IV 62% · EM ±2.6%Jun 19 — IV 40% · EM ±8.8%Jun 22 — IV 44% · EM ±9.1%Jun 23 — IV 42% · EM ±8.5%Jun 24 — IV 42% · EM ±8.3%Jun 25 — IV 40% · EM ±7.9%Jun 26 — IV 38% · EM ±7.3%Jun 29 — IV 41% · EM ±7.3%Jun 30 — IV 40% · EM ±7.0%Jul 01 — IV 41% · EM ±6.9%Jul 02 — IV 42% · EM ±6.8%Jul 03 — IV 43% · EM ±6.8%Jul 06 — IV 44% · EM ±6.1%Jul 07 — IV 47% · EM ±6.3%Jul 08 — IV 44% · EM ±5.6%Jul 09 — IV 45% · EM ±5.3%Jul 10 — IV 46% · EM ±5.0%Jul 13 — IV 51% · EM ±4.3%Jul 14 — IV 55% · EM ±4.0%Jul 15 — IV 57% · EM ±3.3%Jul 16 — IV 61% · EM ±2.6%Jul 20 — IV 50% · EM ±11.9%Jul 21 — IV 51% · EM ±11.8%Jul 22 — IV 49% · EM ±11.3%Jul 23 — IV 51% · EM ±11.6%Jul 24 — IV 51% · EM ±11.2%Jul 27 — IV 54% · EM ±11.3%Jul 28 — IV 57% · EM ±11.6%Jul 29 — IV 42% · EM ±8.5%Jul 30 — IV 44% · EM ±8.6%Jul 31 — IV 44% · EM ±8.4%Aug 03 — IV 46% · EM ±8.2%Aug 04 — IV 47% · EM ±8.0%Aug 05 — IV 46% · EM ±7.7%Aug 06 — IV 45% · EM ±7.3%Aug 07 — IV 42% · EM ±6.6%Aug 10 — IV 49% · EM ±6.7%Aug 11 — IV 39% · EM ±5.2%Aug 12 — IV 42% · EM ±5.3%Aug 13 — IV 45% · EM ±5.3%Aug 14 — IV 41% · EM ±4.5%Aug 17 — IV 58% · EM ±4.8%Aug 18 — IV 49% · EM ±3.5%Aug 19 — IV 71% · EM ±4.2%Aug 20 — IV 68% · EM ±2.8%Aug 24 — IV 40% · EM ±8.3%Aug 25 — IV 38% · EM ±7.8%Aug 26 — IV 35% · EM ±7.0%Aug 27 — IV 36% · EM ±7.1%Aug 28 — IV 36% · EM ±6.8%Aug 31 — IV 37% · EM ±6.6%Sep 01 — IV 40% · EM ±6.8%Sep 02 — IV 39% · EM ±6.5%Sep 03 — IV 37% · EM ±6.0%Sep 04 — IV 37% · EM ±5.7%Sep 07 — IV 41% · EM ±5.7%Sep 08 — IV 42% · EM ±5.6%Sep 09 — IV 40% · EM ±5.0%Sep 10 — IV 41% · EM ±4.9%Sep 11 — IV 39% · EM ±4.3%Sep 14 — IV 49% · EM ±4.1%Sep 15 — IV 54% · EM ±3.9%Sep 16 — IV 42% · EM ±2.5%Sep 17 — IV 129% · EM ±5.4%Sep 21 — IV 36% · EM ±7.4%Sep 22 — IV 37% · EM ±7.6%Sep 23 — IV 35% · EM ±7.1%Sep 24 — IV 37% · EM ±7.3%Sep 25 — IV 38% · EM ±7.2%Sep 28 — IV 41% · EM ±7.2%Sep 29 — IV 40% · EM ±7.0%Sep 30 — IV 38% · EM ±6.3%Oct 01 — IV 38% · EM ±6.1%Oct 02 — IV 39% · EM ±6.0%Oct 06 — IV 42% · EM ±5.5%Oct 07 — IV 37% · EM ±4.7%Oct 08 — IV 37% · EM ±4.4%

Sector peers

UAN
CVR Partners, LP
$1.3B $125.23-1.3%
CBUS
Cibus, Inc.
$125M $1.40+0.7%
AVD
American Vanguard Corporation
$52M $1.06+0.9%
BIOX
Bioceres Crop Solutions Corp.
$22M $0.26+1.2%
EVGN
Evogene Ltd.
$9M $0.38+1.6%
SNES
SenesTech, Inc.
$4M $0.80+16.0%

SMG earnings FAQ

When is SMG's next earnings date?

Scotts Miracle-Gro Company (The) is expected to report on November 4, 2026, before the market opens.

What is SMG's expected move for earnings?

Options currently price a move of about ±4.4%, or $2.61 per share either way from $59.15.

How does SMG stock usually react to earnings?

Across the last 6 reports the average next-day move was ±4.4%, up 1 times and down 5 times.

What EPS are analysts expecting from Scotts Miracle-Gro Company (The)?

The consensus estimate is -$2.22 per share, versus -$1.96 a year ago.

What is SMG's implied volatility?

SMG's at-the-money implied volatility is about 37% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in